4.7 Article

Design, synthesis, and biological evaluation of quinoxalinone derivatives as potent BRD4 inhibitors

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Design, synthesis and biological evaluation of coumarin derivatives as potential BRD4 inhibitors

Qi-Hang Cui et al.

Summary: The structure of BRD(4)i ABBV-075 was modified and a novel series of coumarin derivatives were synthesized as BRD4 inhibitors. Compound 27d showed excellent inhibitory activities against various cancer cells and exhibited good stability, indicating it as a promising lead compound for further drug development.

BIOORGANIC CHEMISTRY (2022)

Article Integrative & Complementary Medicine

Acacetin inhibits invasion, migration and TGF-β1-induced EMT of gastric cancer cells through the PI3K/Akt/Snail pathway

Guangtao Zhang et al.

Summary: Acacetin inhibits proliferation, invasion, and migration of human gastric cancer cells by regulating EMT-related proteins. It reverses morphological changes induced by TGF-beta 1 and restricts invasion and migration by regulating EMT. Acacetin also suppresses PI3K/Akt signaling and delays metastasis in vivo.

BMC COMPLEMENTARY MEDICINE AND THERAPIES (2022)

Article Chemistry, Medicinal

Discovery of selective HDAC/BRD4 dual inhibitors as epigenetic probes

Jingjing Chen et al.

Summary: Selective HDAC/BRD4 dual inhibitors were designed and synthesized using pharmacophore fusion strategy, leading to the identification of three types of inhibitors with different cellular activities. Among them, the selective dual inhibitor 41c showed synergistic effects in inducing cell cycle arrest and apoptosis in MV-4-11 cells. This study supports the use of selective HDAC/BRD4 dual inhibitors as epigenetic probes for future biological evaluation in various cancer cell lines.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Cell Biology

Bromodomain-containing protein 4 and its role in cardiovascular diseases

Liang Li et al.

Summary: BRD4, a chromatin-binding protein, is implicated in the development of various tumors, and recent evidence suggests its significant role in cardiovascular diseases. This review summarizes BRD4's potential as a regulator in cardiovascular pathophysiology, suggesting it may be a new therapeutic target in the future.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Article Medicine, General & Internal

Hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), poses a significant global health challenge with rising incidence projected to exceed 1 million cases by 2025. Infection by hepatitis B and C viruses remains a major risk factor for HCC, while non-alcoholic steatohepatitis is emerging as a more common risk factor in Western countries. Advances in systemic therapies for HCC, including immunotherapies and targeted therapies, are expected to revolutionize the management of this disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

Review Biochemistry & Molecular Biology

The role of distinct BRD4 isoforms and their contribution to high-grade serous ovarian carcinoma pathogenesis

Ana Luiza Drumond-Bock et al.

Summary: HGSOC is the most aggressive type of ovarian cancer with high genomic instability, where BRD4 gene amplification is correlated with poor prognosis. Increased BRD4 activity is associated with malignancy progression, including tumor cells proliferation, genetic instability, epithelial-mesenchymal transition, and metastasis.

MOLECULAR CANCER (2021)

Article Chemistry, Medicinal

Targeting Bromodomain and Extraterminal Proteins for Drug Discovery: From Current Progress to Technological Development

Pan Tang et al.

Summary: BET proteins regulate chromatin dynamics, cellular processes, and disease progression by binding acetylated lysine residues in histones and nonhistone proteins, making them a promising strategy for treating malignant tumors and chronic inflammation. However, the clinical efficacy of current BET inhibitors is limited, leading to the development of new technologies to improve outcomes and minimize side effects.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Oncology

A phase 1 study of the pan-bromodomain and extraterminal inhibitor mivebresib (ABBV-075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemia

Gautam Borthakur et al.

Summary: The study investigated the safety and efficacy of the pan-BET inhibitor mivebresib as monotherapy and in combination with venetoclax in patients with relapsed/refractory AML. Adverse effects of the drug were dose-dependent, and some patients showed improvement in their leukemia. Further studies are needed to determine the potential of mivebresib in treating acute myeloid leukemia.

CANCER (2021)

Review Pharmacology & Pharmacy

The Hexosamine Biosynthetic Pathway Links Innate Inflammation With Epithelial-Mesenchymal Plasticity in Airway Remodeling

Allan R. Brasier et al.

Summary: Disruption of the lower airway epithelial barrier is important in chronic lung disease, with environmental insults triggering metabolic adaptations, epithelial-mesenchymal plasticity, and airway remodeling. The hexosamine biosynthetic pathway links innate inflammation to airway remodeling, and there is crosstalk between the IKK-NF kappa B pathway and the UPR in controlling protein glycosylation and ECM secretion for airway remodeling.

FRONTIERS IN PHARMACOLOGY (2021)

Article Pharmacology & Pharmacy

Bromodomains: A novel target for the anticancer therapy

Shivani Gokani et al.

Summary: Bromodomains are a diverse group of proteins involved in cellular functions, with BRD2 and BRD4 playing critical roles in the cell cycle and oncogenesis. Targeting bromodomain proteins as potential epigenetic targets for cancer treatment is an emerging area of research.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Review Biochemistry & Molecular Biology

The BET family in immunity and disease

Nian Wang et al.

Summary: The BET family plays a crucial role in regulating the transcription of genes associated with inflammation and immunity by recognizing acetylated histones and recruiting transcription factors and elongation complexes. Manipulating the BET family holds promise as a new treatment approach for disease.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Multidisciplinary Sciences

MYC protein stability is negatively regulated by BRD4

Ballachanda N. Devaiah et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Chemistry, Medicinal

Design, synthesis and biological evaluation of indole-2-one derivatives as potent BRD4 inhibitors

Yu Xu et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Endocrinology & Metabolism

Fructose stimulated de novo lipogenesis is promoted by inflammation

Jelena Todoric et al.

NATURE METABOLISM (2020)

Editorial Material Multidisciplinary Sciences

TRANSCRIPTION BRD4 and MYC-clarifying regulatory specificity

Arianna Sabo et al.

SCIENCE (2018)

Review Biochemistry & Molecular Biology

BET Family Protein BRD4: An Emerging Actor in NFκB Signaling in Inflammation and Cancer

Azadeh Hajmirza et al.

BIOMEDICINES (2018)

Editorial Material Cardiac & Cardiovascular Systems

Heart failure BRD4 inhibition slows HF progression

Dario Ummarino

NATURE REVIEWS CARDIOLOGY (2017)

Article Chemistry, Medicinal

Design, synthesis and structure-activity relationships of novel phenylalanine-based amino acids as kainate receptors ligands

Ewa Szymanska et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)

Article Immunology

BRD4 promotes tumor growth and epithelial-mesenchymal transition in hepatocellular carcinoma

Pengfei Zhang et al.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2015)

Review Cell Biology

Molecular mechanisms of epithelial-mesenchymal transition

Samy Lamouille et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)

Article Biochemistry & Molecular Biology

Phospho Switch Triggers Brd4 Chromatin Binding and Activator Recruitment for Gene-Specific Targeting

Shwu-Yuan Wu et al.

MOLECULAR CELL (2013)

Article Biochemistry & Molecular Biology

Brd4 Coactivates Transcriptional Activation of NF-κB via Specific Binding to Acetylated RelA

Bo Huang et al.

MOLECULAR AND CELLULAR BIOLOGY (2009)

Article Multidisciplinary Sciences

Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription

Dwayne A. Bisgrovet et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Chemistry, Organic

Novel approach to 3-methyl-1H-quinoxalin-2-ones

X Li et al.

SYNTHETIC COMMUNICATIONS (2005)

Article Multidisciplinary Sciences

The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis

A Dey et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)